Verisim Life, Inc.
Publicly observedSan Francisco, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Francisco | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Verisim Life, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | YLBHHR2HKLS1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Jul 2025Publicly observed
NIH SBIR/STTR award: Development of therapeutic candidates for stimulant use disorder using AI-driven platform for focused drug discovery and accelerated development
USD 512,644.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
- Grant15 Jul 2025Publicly observed
NIH SBIR/STTR award: Development of therapeutic candidates for stimulant use disorder using AI-driven platform for focused drug discovery and accelerated development
USD 811,876.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.